<?xml version='1.0' encoding='utf-8'?>
<document id="24961684"><sentence text="Simultaneous determination of propofol and remifentanil in rat plasma by liquid chromatography-tandem mass spectrometry: application to preclinical pharmacokinetic drug-drug interaction analysis."><entity charOffset="30-38" id="DDI-PubMed.24961684.s1.e0" text="propofol" /><entity charOffset="43-55" id="DDI-PubMed.24961684.s1.e1" text="remifentanil" /><pair ddi="false" e1="DDI-PubMed.24961684.s1.e0" e2="DDI-PubMed.24961684.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24961684.s1.e0" e2="DDI-PubMed.24961684.s1.e1" /></sentence><sentence text="Propofol (Pro) is an ultra-short-acting hypnotic agent used for general anesthesia that has no analgesic properties"><entity charOffset="0-8" id="DDI-PubMed.24961684.s2.e0" text="Propofol" /><entity charOffset="10-13" id="DDI-PubMed.24961684.s2.e1" text="Pro" /><pair ddi="false" e1="DDI-PubMed.24961684.s2.e0" e2="DDI-PubMed.24961684.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24961684.s2.e0" e2="DDI-PubMed.24961684.s2.e1" /></sentence><sentence text=" Remifentanil (Rem) is an ultra-short-acting opioid administered concomitantly as an analgesic with Pro"><entity charOffset="1-13" id="DDI-PubMed.24961684.s3.e0" text="Remifentanil" /><entity charOffset="45-51" id="DDI-PubMed.24961684.s3.e1" text="opioid" /><entity charOffset="100-105" id="DDI-PubMed.24961684.s3.e2" text="Pro" /><pair ddi="false" e1="DDI-PubMed.24961684.s3.e0" e2="DDI-PubMed.24961684.s3.e0" /><pair ddi="false" e1="DDI-PubMed.24961684.s3.e0" e2="DDI-PubMed.24961684.s3.e1" /><pair ddi="false" e1="DDI-PubMed.24961684.s3.e0" e2="DDI-PubMed.24961684.s3.e2" /><pair ddi="false" e1="DDI-PubMed.24961684.s3.e1" e2="DDI-PubMed.24961684.s3.e1" /><pair ddi="false" e1="DDI-PubMed.24961684.s3.e1" e2="DDI-PubMed.24961684.s3.e2" /></sentence><sentence text=" To evaluate the pharmacokinetic interactions between Pro and Rem, we developed and validated a method combining high-performance liquid chromatography with tandem mass spectrometry for simultaneous determination of Pro and Rem"><entity charOffset="54-56" id="DDI-PubMed.24961684.s4.e0" text="Pro" /><entity charOffset="216-218" id="DDI-PubMed.24961684.s4.e1" text="Pro" /><pair ddi="false" e1="DDI-PubMed.24961684.s4.e0" e2="DDI-PubMed.24961684.s4.e0" /><pair ddi="false" e1="DDI-PubMed.24961684.s4.e0" e2="DDI-PubMed.24961684.s4.e1" /></sentence><sentence text=" The proposed method was successfully used to study the pharmacokinetic interactions of Pro and Rem coadministered to rats"><entity charOffset="88-90" id="DDI-PubMed.24961684.s5.e0" text="Pro" /></sentence><sentence text="" /></document>